Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection
Abstract Aims Acute cellular rejection (ACR) following heart transplantation (HTX) is associated with long‐term graft loss and increased mortality. Disturbed mitochondrial bioenergetics have been identified as pathophysiological drivers in heart failure, but their role in ACR remains unclear. We aimed to prove functional disturbances of myocardial bioenergetics in human heart transplant recipients with mild ACR by assessing myocardial mitochondrial respiration using high‐resolution respirometry, digital image analysis of myocardial inflammatory cell infiltration, and clinical assessment of HTX patients. We hypothesized that (i) mild ACR is associated with impaired myocardial mitochondrial respiration and (ii) myocardial inflammation, systemic oxidative stress, and myocardial oedema relate to impaired mitochondrial respiration and myocardial dysfunction. Methods and results We classified 35 HTX recipients undergoing endomyocardial biopsy according International Society for Heart and Lung Transplantation criteria to have no (0R) or mild (1R) ACR. Additionally, we quantified immune cell infiltration by immunohistochemistry and digital image analysis. We analysed mitochondrial substrate utilization in myocardial fibres by high‐resolution respirometry and performed cardiovascular magnetic resonance (CMR). ACR (1R) was diagnosed in 12 patients (34%), while the remaining 23 patients revealed no signs of ACR (0R). Underlying cardiomyopathies (dilated cardiomyopathy 50% vs. 65%; P = 0.77), comorbidities (type 2 diabetes mellitus: 50% vs. 35%, P = 0.57; chronic kidney disease stage 5: 8% vs. 9%, P < 0.99; arterial hypertension: 59% vs. 30%, P = 0.35), medications (tacrolimus: 100% vs. 91%, P = 0.54; mycophenolate mofetil: 92% vs. 91%, P < 0.99; prednisolone: 92% vs. 96%, P < 0.99) and time post‐transplantation (21.5 ± 26.0 months vs. 29.4 ± 26.4 months, P = 0.40) were similar between groups. Mitochondrial respiration was reduced by 40% in ACR (1R) compared with ACR (0R) (77.8 ± 23.0 vs. 128.0 ± 33.0; P < 0.0001). Quantitative assessment of myocardial CD3+‐lymphocyte infiltration identified ACR (1R) with a cut‐off of <14 CD3+‐lymphocytes/mm2 (100% sensitivity, 82% specificity; P < 0.0001). Myocardial CD3+ infiltration (r = −0.41, P < 0.05), systemic oxidative stress (thiobarbituric acid reactive substances; r = −0.42, P < 0.01) and myocardial oedema depicted by global CMR derived T2 time (r = −0.62, P < 0.01) correlated with lower oxidative capacity and overt cardiac dysfunction (global longitudinal strain; r = −0.63, P < 0.01). Conclusions Mild ACR with inflammatory cell infiltration associates with impaired mitochondrial bioenergetics in cardiomyocytes. Our findings may help to identify novel checkpoints in cardiac immune metabolism as potential therapeutic targets in post‐transplant care..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
ESC Heart Failure - 8(2021), 6, Seite 4674-4684 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Daniel Scheiber [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Acute cellular heart transplant rejection |
|---|
| doi: |
10.1002/ehf2.13607 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ041846362 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ041846362 | ||
| 003 | DE-627 | ||
| 005 | 20230308052903.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ehf2.13607 |2 doi | |
| 035 | |a (DE-627)DOAJ041846362 | ||
| 035 | |a (DE-599)DOAJe8036e0392b74ca2bb14186c345d3d80 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC666-701 | |
| 100 | 0 | |a Daniel Scheiber |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Aims Acute cellular rejection (ACR) following heart transplantation (HTX) is associated with long‐term graft loss and increased mortality. Disturbed mitochondrial bioenergetics have been identified as pathophysiological drivers in heart failure, but their role in ACR remains unclear. We aimed to prove functional disturbances of myocardial bioenergetics in human heart transplant recipients with mild ACR by assessing myocardial mitochondrial respiration using high‐resolution respirometry, digital image analysis of myocardial inflammatory cell infiltration, and clinical assessment of HTX patients. We hypothesized that (i) mild ACR is associated with impaired myocardial mitochondrial respiration and (ii) myocardial inflammation, systemic oxidative stress, and myocardial oedema relate to impaired mitochondrial respiration and myocardial dysfunction. Methods and results We classified 35 HTX recipients undergoing endomyocardial biopsy according International Society for Heart and Lung Transplantation criteria to have no (0R) or mild (1R) ACR. Additionally, we quantified immune cell infiltration by immunohistochemistry and digital image analysis. We analysed mitochondrial substrate utilization in myocardial fibres by high‐resolution respirometry and performed cardiovascular magnetic resonance (CMR). ACR (1R) was diagnosed in 12 patients (34%), while the remaining 23 patients revealed no signs of ACR (0R). Underlying cardiomyopathies (dilated cardiomyopathy 50% vs. 65%; P = 0.77), comorbidities (type 2 diabetes mellitus: 50% vs. 35%, P = 0.57; chronic kidney disease stage 5: 8% vs. 9%, P < 0.99; arterial hypertension: 59% vs. 30%, P = 0.35), medications (tacrolimus: 100% vs. 91%, P = 0.54; mycophenolate mofetil: 92% vs. 91%, P < 0.99; prednisolone: 92% vs. 96%, P < 0.99) and time post‐transplantation (21.5 ± 26.0 months vs. 29.4 ± 26.4 months, P = 0.40) were similar between groups. Mitochondrial respiration was reduced by 40% in ACR (1R) compared with ACR (0R) (77.8 ± 23.0 vs. 128.0 ± 33.0; P < 0.0001). Quantitative assessment of myocardial CD3+‐lymphocyte infiltration identified ACR (1R) with a cut‐off of <14 CD3+‐lymphocytes/mm2 (100% sensitivity, 82% specificity; P < 0.0001). Myocardial CD3+ infiltration (r = −0.41, P < 0.05), systemic oxidative stress (thiobarbituric acid reactive substances; r = −0.42, P < 0.01) and myocardial oedema depicted by global CMR derived T2 time (r = −0.62, P < 0.01) correlated with lower oxidative capacity and overt cardiac dysfunction (global longitudinal strain; r = −0.63, P < 0.01). Conclusions Mild ACR with inflammatory cell infiltration associates with impaired mitochondrial bioenergetics in cardiomyocytes. Our findings may help to identify novel checkpoints in cardiac immune metabolism as potential therapeutic targets in post‐transplant care. | ||
| 650 | 4 | |a Acute cellular heart transplant rejection | |
| 650 | 4 | |a Mitochondrial respiration | |
| 650 | 4 | |a Myocardial inflammation | |
| 650 | 4 | |a Heart failure | |
| 653 | 0 | |a Diseases of the circulatory (Cardiovascular) system | |
| 700 | 0 | |a Elric Zweck |e verfasserin |4 aut | |
| 700 | 0 | |a Sophie Albermann |e verfasserin |4 aut | |
| 700 | 0 | |a Tomas Jelenik |e verfasserin |4 aut | |
| 700 | 0 | |a Maximilian Spieker |e verfasserin |4 aut | |
| 700 | 0 | |a Florian Bönner |e verfasserin |4 aut | |
| 700 | 0 | |a Patrick Horn |e verfasserin |4 aut | |
| 700 | 0 | |a Heinz‐Peter Schultheiss |e verfasserin |4 aut | |
| 700 | 0 | |a Ganna Aleshcheva |e verfasserin |4 aut | |
| 700 | 0 | |a Felicitas Escher |e verfasserin |4 aut | |
| 700 | 0 | |a Udo Boeken |e verfasserin |4 aut | |
| 700 | 0 | |a Payam Akhyari |e verfasserin |4 aut | |
| 700 | 0 | |a Michael Roden |e verfasserin |4 aut | |
| 700 | 0 | |a Malte Kelm |e verfasserin |4 aut | |
| 700 | 0 | |a Julia Szendroedi |e verfasserin |4 aut | |
| 700 | 0 | |a Ralf Westenfeld |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t ESC Heart Failure |d Wiley, 2015 |g 8(2021), 6, Seite 4674-4684 |w (DE-627)DOAJ000097977 |x 20555822 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2021 |g number:6 |g pages:4674-4684 |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ehf2.13607 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/e8036e0392b74ca2bb14186c345d3d80 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ehf2.13607 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2055-5822 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2021 |e 6 |h 4674-4684 | ||